Sponsor Pipeline

Guangdong Second Provincial General Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
2
Recruiting
1
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Early Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07537257 VEN+IDAC vs IDAC in AML AML (Acute Myelogenous Leukemia) Enrolling by Invitation
Phase 2
NCT07517510 HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL). Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL) Enrolling by Invitation
Phase 1/2
NCT07663864 Luspatercept for CIA in AML Chemotherapy-inducing Anemia Recruiting
Early Phase 1
NCT06298266 To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in… Relapsed or Refractory Multiple Myeloma Not Yet Recruiting
Not specified
NCT06758609 To Assess the Effectiveness and Safety of Catheter-based Focal Intracranial Hypothermia… Acute Cerebrovascular Accident Recruiting
NCT06834555 Mobile Phone Thermal Imaging Assessment of Incompetent Perforator Veins Chronic Venous Disease Not Yet Recruiting
Disease Areas
Leukemia (2) Multiple Myeloma (1) Stroke (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Guangdong Second Provincial General Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free